Fig. 3 | Scientific Reports

Fig. 3

From: Investigation of the cytotoxic effects and mechanisms of the SLC39A6-targeting ADC drug BRY812 in CRC

Fig. 3

SLC39A6 exhibits spatial co-localization with tumor-associated pathways. (A) Comparison of various pathways between two clusters in tumor slides. (B) Correlation analysis between SLC39A6 and tumor pathways. (C) Spatial plots show the expression of SLC39A6 and the ssGSEA scores of tumor pathways. The spatial scatter plot above illustrates their spatial distribution: deeper colors indicate higher expression levels. The line graph below displays expression changes of SLC39A6 and pathway scores along the direction of the arrow.*P < 0.05; **P < 0.01; ***P < 0.001.

Back to article page